Stock Market News
ReNeuron appoints Richard Beckman as chief medical officer
AIM-listed stem cell research company ReNeuron has appointed Richard Beckman as chief medical officer, replacing Julian Howell, who has left to pursue other opportunities.
Beckman, who has more than 25 years of executive and consultancy experience in drug and device development, will be based in the group's recently-established US office in Boston, where he will lead the clinical and medical affairs team.
Before joining ReNeuron, Beckman was the chief medical officer of several innovative biotech and device firms, including Clearside, Ophthotech and Neurotech. Prior to that, he held leadership roles at Alcon, Lux Bio, Becton Dickinson and Allergan.
Chief executive officer Olav Hellebø said: "I am delighted to welcome Rick to the company's management team. His many years' experience in medical practice and industry in the US will be invaluable to us as we build out our Boston team and increase our clinical activities in the US.
"I would like to express my sincere thanks on behalf of the company to Julian Howell who has led our clinical and medical team so skillfully. We wish him well in his next endeavour."
At 1340 BST, the shares were down 1% to 81.20p.
Beckman, who has more than 25 years of executive and consultancy experience in drug and device development, will be based in the group's recently-established US office in Boston, where he will lead the clinical and medical affairs team.
Before joining ReNeuron, Beckman was the chief medical officer of several innovative biotech and device firms, including Clearside, Ophthotech and Neurotech. Prior to that, he held leadership roles at Alcon, Lux Bio, Becton Dickinson and Allergan.
Chief executive officer Olav Hellebø said: "I am delighted to welcome Rick to the company's management team. His many years' experience in medical practice and industry in the US will be invaluable to us as we build out our Boston team and increase our clinical activities in the US.
"I would like to express my sincere thanks on behalf of the company to Julian Howell who has led our clinical and medical team so skillfully. We wish him well in his next endeavour."
At 1340 BST, the shares were down 1% to 81.20p.
Related share prices |
---|
ReNeuron Group (RENE) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price